Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Mahmoud, Mona F ^a   Hassan, Noura A ^a   El Bassossy, Hany M ^a,b   Fahmy, Ahmed ^a  

^a Zagazig University   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PHENYLEPHRINE; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN RESISTANCE; MALE; MORBIDITY; MORTALITY; NONHUMAN; RAT; STREPTOZOCIN DIABETES; THORACIC AORTA; VASOCONSTRICTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AORTA, THORACIC; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIUM; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LEUKOCYTES; MALE; NF-KAPPA B; QUERCETIN; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION;

EID: 84878083345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063784     Document Type: Article

References (73)

1. Ergul A, (2011) Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacological Research 63: 477-482.
2. Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, et al. (2006) Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets. Pharmacology & Therapeutics 111: 384-399.
3. Donath MY, Shoelson SE, (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
4. Goldfine AB, Fonseca V, Shoelson SE, (2011) Therapeutic approaches to target inflammation in type 2 diabetes. Clin Chem 57: 162-167.
5. Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Garcia-Perez J, (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7: 327-340.
6. Pickup JC, (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27: 813-823.
7. Fong Y, Moldawer LL, Shires GT, Lowry SF, (1990) The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 170: 363-378.
8. Cohuet G, Struijker-Boudier H, (2006) Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther 111: 81-98.
9. Wyllie AH, (1997) Apoptosis: an overview. Br Med Bull 53: 451-465.
10. Kunkel EJ, Jung U, Bullard DC, Norman KE, Wolitzky BA, et al. (1996) Absence of trauma-induced leukocyte rolling in mice deficient in both P- selectin and intercellular adhesion molecule 1. J Exp Med 183: 57-65.
11. Peyroux J, Sternberg M, (2006) Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathologie Biologie 54: 405-419.
12. Wang HR, Li JJ, Huang CX, Jiang H, (2005) Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein. Clin Chim Acta 353: 53-60.
13. Tan K, (2004) Dyslipidaemia, inflammation and endothelial dysfunction in diabetes mellitus. International Congress Series 1262: 511-514.
14. Punithavathi VR, Prince PSM, (2009) Combined effects of quercetin and α-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats. Chemico-Biological Interactions 181: 322-327.
15. Hertog MG, Bueno-de-Mesquita HB, Fehily AM, Sweetnam PM, Elwood PC, et al. (1996) Fruit and vegetable consumption and cancer mortality in the Caerphilly Study. Cancer Epidemiol Biomarkers Prev 5: 673-677.
16. Kawakami Y, Hosokawa T, Morinaka T, Irino S, Hirano S, et al. (2012) Antiatherogenic effect of guava leaf extracts inhibiting leucocyte-type 12-lipoxygenase activity. Food Chemistry 131: 1069-1075.
17. Shoskes DA, Nickel JC, (2011) Quercetin for chronic prostatitis/chronic pelvic pain syndrome. Urologic Clinics of North America 38: 279-284.
18. Liu X, Zhao M, Wu K, Chai X, Yu H, et al. (2012) Immunomodulatory and anticancer activities of phenolics from emblica fruit (Phyllanthus emblica L.). Food Chemistry 131: 685-690.
19. Alvarez A, Pomar F, Sevilla MA, Montero MJ, (1999) Gastric antisecretory and antiulcer activities of an ethanolic extract of Bidens pilosa L. var. radiata Schult. Bip. Journal of Ethnopharmacology 67: 333-340.
20. Ajay M, Achike FI, Mustafa AM, Mustafa MR, (2006) Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice 73: 1-7.
21. Cirico T, Omaye ST, (2006) Additive or synergetic effects of phenolic compounds on human low density lipoprotein oxidation. Food and Chemical Toxicology 44: 510-516.
22. Tsimogiannis DI, Oreopoulou V, (2006) The contribution of flavonoid C-ring on the DPPH free radical scavenging efficiency. A kinetic approach for the 3′, 4′-hydroxy substituted members. Innovative Food Science & Emerging Technologies 7: 140-146.
23. Tribolo S, Lodi F, Connor C, Suri S, Wilson VG, et al. (2008) Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197: 50-56.
24. Carlstrom J, Symons JD, Wu TC, Bruno RS, Litwin SE, et al. (2007) A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats. J Nutr 137: 628-633.
25. Manach C, Morand C, Texier O, Favier ML, Agullo G, et al. (1995) Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 125: 1911-1922.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
27. El-Bassossy HM, Fahmy A, Badawy D, (2011) Cinnamaldehyde protects from the hypertension associated with diabetes. Food and Chemical Toxicology 49: 3007-3012.
28. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, et al. (2002) Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 22: 21-27.
29. Mythili MD, Vyas R, Akila G, Gunasekaran S, (2004) Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 63: 274-281.
30. Li JM, Wang C, Hu QH, Kong LD, (2008) Fructose induced leptin dysfunction and improvement by quercetin and rutin in rats. Chinese Journal of Natural Medicines 6: 466-473.
31. Mansour SM, Bahgat AK, El-Khatib AS, Khayyal MT, (2011) Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K, 1C hypertensive rats: Role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction. Phytomedicine 18: 641-647.
32. Ansarullah, Bharucha B, Patel V, Ramachandran AV, (2010) Oreocnide integrifolia (Gaud.) Miq leaf water extract improves metabolic alterations in high fructose fed insulin resistant and hypertensive rats. European Journal of Integrative Medicine 2: 79-87.
33. Shahid M, Francis J, Majid DSA, (2008) Tumor necrosis factor-{alpha} induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol 295: F1836-F1844.
34. El-Bassossy HM, El-Moselhy MA, Mahmoud MF, (2011) Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol 384: 277-285.
35. Ghanem FA, Movahed A, (2007) Inflammation in high blood pressure: a clinician perspective. Journal of the American Society of Hypertension 1: 113-119.
36. Ridker PM, (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369.
37. Jain SK, Rains JL, Croad JL, (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radical Biology and Medicine 43: 1124-1131.
38. Meshkani R, Adeli K, (2009) Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clinical Biochemistry 42: 1331-1346.
39. Bhaskar S, Kumar KS, Krishnan K, Antony H, (2013) Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutrition 29: 219-229.
40. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, et al. (1989) Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59: 1203-1211.
41. Ming WJ, Bersani L, Mantovani A, (1987) Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 138: 1469-1474.
42. Shiomi T, Tsutsui H, Ikeuchi M, Matsusaka H, Hayashidani S, et al. (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42: 165-172.
43. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, et al. (2001) Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Research and Clinical Practice 52: 119-123.
44. Aikawa R, Nitta-Komatsubara Y, Kudoh S, Takano H, Nagai T, et al. (2002) Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-α. Cytokine 18: 179-183.
45. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, et al. (2005) Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179: 43-49.
46. Fan X, Subramaniam R, Weiss MF, Monnier VM, (2003) Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappa β and intracellular reactive oxygen species formation. Archives of Biochemistry and Biophysics 409: 274-286.
47. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, et al. (2006) The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-{kappa}{beta} system. Clin Vaccine Immunol 13: 319-328.
48. Libby P, Ridker PM, Maseri A, (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
49. Rial NS, Choi K, Nguyen T, Snyder B, Slepian MJ, (2012) Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?. Medical Hypotheses 78: 29-32.
50. Iwasaki Y, Kambayashi M, Asai M, Yoshida M, Nigawara T, et al. (2007) High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. Journal of Diabetes and its Complications 21: 56-62.
51. Liu X, Luo D, Zheng M, Hao Y, Hou L, et al. (2010) Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NAPDH oxidase and NF kappa B activation. European Journal of Pharmacology 629: 153-158.
52. Hattori Y, Matsumura M, Kasai K, (2003) Vascular smooth muscle cell activation by C-reactive protein. Cardiovascular Research 58: 186-195.
53. Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, et al. (2005) Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 2088-2093.
54. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, et al. (2006) The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-{kappa}{beta} System. Clin Vaccine Immunol 13: 319-328.
55. Garcίa-Mediavilla V, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, et al. (2007) The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. European Journal of Pharmacology 557: 221-229.
56. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S, (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115: 245-253.
57. Mahmoud M, El-Nagar M, El-Bassossy H, (2012) Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Archives of Pharmacal Research 35: 155-162.
58. Wang L, Xing XP, Holmes A, Wadham C, Gamble JR, et al. (2005) Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res 97: 891-899.
59. Liu CM, Ma JQ, Sun YZ, (2010) Quercetin protects the rat kidney against oxidative stress-mediated DNA damage and apoptosis induced by lead. Environmental Toxicology and Pharmacology 30: 264-271.
60. Kesava R, (2004) AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvascular Research 68: 132-142.
61. Hill BJF, Dixon JL, Sturek M, (2001) Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 159: 117-124.
62. Rekhter MD, (1999) Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res 41: 376-384.
63. Jesus Mn, (1995) Age-related changes in vascular responses: a review. Mechanisms of Ageing and Development 79: 71-114.
64. DeFronzo RA, Ferrannini E, (1991) Insulin Resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.
65. Huang BF, Wang W, Fu YC, Zhou XH, Wang X, (2009) The effect of quercetin on neointima formation in a rat artery balloon injury model. Pathology- Research and Practice 205: 515-523.
66. Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S, (1998) Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 181: 1-9.
67. Southerland JH, Moss K, Taylor GW, Beck JD, Pankow J, et al. (2012) Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis 222: 196-201.
68. El-Bassossy HM, Fahmy A, El-Fawal R, (2012) Arginase inhibition alleviates hypertension associated with diabetes: Effect on endothelial dependent relaxation and NO production. Vascul Pharmacol 57: 194-200.
69. Danielsen R, Nordrehaug JE, Lien E, Vik-Mo H, (1987) Subclinical left ventricular abnormalities in young subjects with long-term type 1 diabetes mellitus detected by digitized m-mode echocardiography. The American Journal of Cardiology 60: 143-146.
70. Fukui M, Kitagawa Y, Nakamura N, Mogami S, Ohnishi M, et al. (2003) Augmentation of central arterial pressure as a marker of atherosclerosis in patients with type 2 diabetes. Diabetes Research and Clinical Practice 59: 153-161.
71. Romero M, Jiménez R, Hurtado Bn, Moreno JM, Rodríguez-Gómez I, et al. (2010) Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. European Journal of Pharmacology 627: 242-250.
72. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, et al. (2003) Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 243: 153-160.
73. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, et al. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460.